Press release
IgA Nephropathy Market to Grow Positively at a Paltry CAGR During the Study Period, DelveInsight | Calliditas Therapeutics AB, Travere Therapeutics, Omeros, Novartis Pharmaceuticals, Chinook Therapeutics, Vera Therapeutics
IgA Nephropathy Market
Key highlights from the IgA Nephropathy market report:
Key IgA Nephropathy companies working in the market are Calliditas Therapeutics AB, Travere Therapeutics, Omeros, Novartis Pharmaceuticals, Chinook Therapeutics, Vera Therapeutics, and others.
To know more about IgA Nephropathy, visit: https://www.delveinsight.com/report-store/iga-nephropathy-igan-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
IgA Nephropathy Overview
IgAN (Immunoglobulin A Nephropathy) is an autoimmune condition that targets the kidneys, impairing their ability to filter blood effectively. This disorder arises when abnormal proteins cause damage to the glomeruli, the tiny filtering units within the kidneys.
IgA Nephropathy Epidemiological Insights
In 2021, the total number of prevalent IgAN cases across the 7MM and China was approximately 1.7 million.
Download our report @ https://www.delveinsight.com/report-store/iga-nephropathy-igan-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
IgA Nephropathy Treatment Market
The treatment landscape for IgAN has been primarily dominated by ACE inhibitors (ACEi), angiotensin receptor blockers (ARBs), and immunosuppressants. In December 2021, the US FDA approved TARPEYO (budesonide) delayed-release capsules for patients at high risk of rapid disease progression, typically those with a urine protein-to-creatinine ratio (UPCR) ≥1.5g/g. This marked the first and only therapy specifically indicated to reduce proteinuria in adults with primary IgAN. Despite this advancement, no other targeted therapies for IgAN are currently approved, although several new treatments are in development.
Promising Therapies in the IgA Nephropathy Pipeline
Tarpeyo
Sparsentan
And others
Discover more about IgA Nephropathy therapies in the pipeline @ https://www.delveinsight.com/sample-request/iga-nephropathy-igan-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Leading Companies Working in the IgA Nephropathy Market
Calliditas Therapeutics AB
Travere Therapeutics, Inc
And others
To understand key companies related to the IgA Nephropathy Market, get a snapshot of the IgA Nephropathy Regulatory and Patent Analysis @ https://www.delveinsight.com/sample-request/iga-nephropathy-igan-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Scope of the IgA Nephropathy Market Report
Study Period: 2020-2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]
Key IgA Nephropathy Companies: Calliditas Therapeutics AB, Travere Therapeutics, Inc, and others
Key IgA Nephropathy Pipeline Therapies: Tarpeyo, Sparsentan, and others
Therapeutic Assessment: IgA Nephropathy current marketed and emerging therapies
IgA Nephropathy Market Dynamics: IgA Nephropathy market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL's views, Analyst's views, IgA Nephropathy Market Access and Reimbursement
Table of Contents
1. IgA Nephropathy Market Key Insights
2. IgA Nephropathy Market Report Introduction
3. IgA Nephropathy Market Overview at a Glance
4. IgA Nephropathy Market Executive Summary
5. Disease Background and Overview
6. IgA Nephropathy Treatment and Management
7. IgA Nephropathy Epidemiology and Patient Population
8. Patient Journey
9. IgA Nephropathy Emerging Drugs
10. 7MM IgA Nephropathy Market Analysis
11. IgA Nephropathy Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. IgA Nephropathy Market Drivers
15. IgA Nephropathy Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
Contact Us
Kritika Rehani
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release IgA Nephropathy Market to Grow Positively at a Paltry CAGR During the Study Period, DelveInsight | Calliditas Therapeutics AB, Travere Therapeutics, Omeros, Novartis Pharmaceuticals, Chinook Therapeutics, Vera Therapeutics here
News-ID: 3644273 • Views: …
More Releases from DelveInsight Business Research LLP
Pharmaceutical Contract Manufacturing Market Forecast Report 2032: Size, Share, …
DelveInsight's Pharmaceutical Contract Manufacturing Market Insights Report 2032 provides the current and forecast market analysis, individual leading Pharmaceutical Contract Manufacturing Companies market shares, challenges, Pharmaceutical Contract Manufacturing Market Drivers, barriers, trends, and key market Pharmaceutical Contract Manufacturing companies in the market.
To read more about the latest highlights related to the Pharmaceutical Contract Manufacturing Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/pharmaceutical-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key…
Pharmaceuticals Market Forecast Report 2032: Size, Share, and Strategic Insights …
DelveInsight's Pharmaceuticals Market Insights Report 2032 provides the current and forecast market analysis, individual leading Pharmaceuticals Companies market shares, challenges, Pharmaceuticals Market Drivers, barriers, trends, and key market Pharmaceuticals companies in the market.
To read more about the latest highlights related to the Pharmaceuticals Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/pharmaceutical-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Pharmaceuticals Market Report
• In July 2025, Sanofi announced the…
Checkpoint Inhibitors Competitive Landscape Report 2025: Emerging Therapies, Lea …
DelveInsight's, "Checkpoint Inhibitors Competitive landscape 2025" report provides comprehensive insights about 50+ companies and 60+ drugs in Checkpoint Inhibitors Competitive landscape. It covers the Checkpoint Inhibitors Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the full insights into the evolving Checkpoint Inhibitors Pipeline and discover which companies are leading the innovation race @ Checkpoint Inhibitors Competitive…
Surgical Simulation Market Forecast Report 2032: Size, Share, and Strategic Insi …
DelveInsight's Surgical Simulation Market Insights Report 2032 provides the current and forecast market analysis, individual leading Surgical Simulation Companies market shares, challenges, Surgical Simulation Market Drivers, barriers, trends, and key market Surgical Simulation companies in the market.
To read more about the latest highlights related to the Surgical Simulation Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/surgical-simulation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Surgical Simulation Market…
More Releases for IgA
Multiplier Strengthens Identity Governance with Advanced IGA Solutions
Image: https://www.abnewswire.com/upload/2025/08/8c79c8224ecce453d70ad648fa16d5e9.jpg
Introduction
In today's rapidly evolving digital landscape, managing user identities and access rights has become a critical concern for businesses of all sizes. As organizations expand, ensuring the right individuals have the correct access to systems and data is essential for operational efficiency and security. Multiplier, a leader in innovative enterprise solutions, is empowering companies with comprehensive Identity Governance and Administration (IGA) solutions to address these challenges.
IGA Solutions: The Heart…
IgA Nephropathy Market Positioned for Accelerated Development Through 2032, Delv …
The Key IgA Nephropathy Companies in the market include - Travere Therapeutics, Asahi Kasei (Calliditas Therapeutics), Vertex Pharmaceuticals, Vera Therapeutics, Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences, Shanghai Alebund Pharmaceuticals, Rohto Pharmaceutical, Wuhan Createrna Science and Technology, Guangdong Hengrui Pharmaceutical, LRx Ionis Pharmaceuticals, Jiangsu HengRui Medicine Co., Ltd., Travere Therapeutics, and others.
DelveInsight's "IgA Nephropathy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the IgA Nephropathy,…
IgA Nephropathy Market to Reach New Heights in Growth by 2034, DelveInsight Pred …
The Key IgA Nephropathy Companies in the market include - Travere Therapeutics, Asahi Kasei (Calliditas Therapeutics), Vertex Pharmaceuticals, Vera Therapeutics, Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences, Shanghai Alebund Pharmaceuticals, Rohto Pharmaceutical, Wuhan Createrna Science and Technology, Guangdong Hengrui Pharmaceutical, LRx Ionis Pharmaceuticals, Jiangsu HengRui Medicine Co., Ltd., Travere Therapeutics, and others.
DelveInsight's "IgA Nephropathy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the IgA Nephropathy,…
IgA Nephropathy Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, IgA Nephropathy pipeline constitutes 30+ key companies continuously working towards developing 30+ IgA Nephropathy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The IgA Nephropathy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
IgA Nephropathy Drugs Market Trends And Forecast 2023-2030
Innovations and Growth Propel IgA Nephropathy Drugs Market:
Global IgA Nephropathy Drugs Market Expands with Technological Advancements and Research Initiatives
The IgA nephropathy drugs market is witnessing a surge in product launches driven by advancements in technology and an upswing in research and development activities. IgA nephropathy, an autoimmune disease affecting the kidneys, results in inflammation and kidney damage due to the accumulation of antibody clumps. The market is experiencing notable growth,…
IgA Nephropathy Drugs Market Sales, Demands and Forecasts
The IgA Nephropathy Drugs market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
